NewcelX Ltd. (NCEL) Stock

NASDAQ: NCELHealthcare company in the biotechnology industry, based in Kloten, USA.

NewcelX stock price chart

NCEL interactive chart →

NCEL stock quote & key statistics

NewcelX earnings per share

Income →
Earnings per share

NewcelX revenue & net income

Income →
RevenueNet income

NewcelX annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$0-$8.3M—
FY2024$0-$2.0M—
FY2023$0-$12.2M—
FY2022$0-$16.5M—
FY2021$0-$11.9M-$2.17

Fiscal year ending December 31. Source: company filings via EODHD.

About NewcelX Ltd.

NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications; and Dual Orexin-Receptor Agonist (DOXA), a small molecules platform for the treatment of sleep disorders, Neurodegenerative/ neuroinflammation diseases, and Diabetes Associated Neurological Disorders. It also develops iTOL-102, NCEL-201, NCEL-301, and NCEL-007. NewcelX Ltd. was founded in 2008 and is headquartered in Kloten, Switzerland.

NewcelX stock FAQ

What is the NewcelX stock ticker symbol?

NewcelX Ltd. trades on the NASDAQ under the ticker symbol NCEL.

What sector and industry is NewcelX in?

NewcelX Ltd. is classified in the Healthcare sector, Biotechnology industry.

How many employees does NewcelX have?

NewcelX Ltd. has about 9 full-time employees.

What were NewcelX's revenue and earnings last fiscal year?

NewcelX reported revenue of $0 and net income of -$8.3M in fiscal 2025.

When did NewcelX go public?

NewcelX stock began trading on January 29, 2021.

Biotechnology stocks

All Healthcare stocks →